Sign in
4

Changes in Ownership

Immunocore Holdings plc Filed Acc 0001955244-25-000008

HEAD OF R&D sold 61,849 shares at $35.23 ($2,178,940)

  • HEAD OF R&D acquired 61,849 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Berman David M · HEAD OF R&D

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-09-30 Exercise or conversion : show line 1 in the form 10b5-1 +61,849 $17.46 $1,079,884 61,849 D
2025-09-30 Sale : show line 2 in the form 10b5-1 −61,849 $35.23 $2,178,940 0 D
Open-market sales · 61,849 sh · avg $35.23 · $2,178,940

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-09-30 Exercise or conversion : show line 3 in the form 10b5-1 Employee Share Option (Right to Buy) −61,849 136,790 D
Loading xslF345X05/form4-10022025_041002.xml…